Li Bian
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 41
- HER2/EGFR in Cancer Research 16
- Cancer Treatment and Pharmacology 11
- Cancer Cells and Metastasis 10
- Peptidase Inhibition and Analysis 5
-
- Lung Cancer Treatments and Mutations 6
- Advanced Breast Cancer Therapies 5
- Co-authors
- Zefei Jiang (33 shared papers)Shaohua Zhang (29 shared papers)Xiao‐Jing Wang (14 shared papers)Gangwen Han (7 shared papers)Yongwen He (12 shared papers)Christian D. Young (9 shared papers)Yi Liu (7 shared papers)Bing Liu (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Investigative Dermatology (3 papers)Annals of Translational Medicine (3 papers)The Oncologist (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Li Bian
111 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 114
- Oncology 402
- Cancer Research 184
- Otorhinolaryngology 45
- Pulmonary and Respiratory Medicine 209
- Genetics 60
Countries citing papers authored by Li Bian
This map shows the geographic impact of Li Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Bian more than expected).
Fields of papers citing papers by Li Bian
This network shows the impact of papers produced by Li Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Bian. The network helps show where Li Bian may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2013 | 71 | |
| 3 | 2013 | 64 | |
| 4 | 2003 | 57 | |
| 5 | 2015 | 41 | |
| 6 | 2017 | 39 | |
| 7 | In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. | 2009 | 38 |
| 8 | 2016 | 29 | |
| 9 | 2018 | 28 | |
| 10 | 2016 | 28 | |
| 11 | 2018 | 27 | |
| 12 | 2021 | 27 | |
| 13 | 2019 | 26 | |
| 14 | 2020 | 25 | |
| 15 | 2005 | 25 | |
| 16 | 2019 | 23 | |
| 17 | 2015 | 20 | |
| 18 | 2019 | 19 | |
| 19 | 2013 | 18 | |
| 20 | 2018 | 17 |
About Li Bian
Li Bian is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Epidemiology, having authored 125 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Cancer Treatment and Pharmacology (11 papers), Cancer Cells and Metastasis (10 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Peptidase Inhibition and Analysis (5 papers), Advanced Breast Cancer Therapies (5 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Oncology (402 citations), Cancer Research (184 citations), Otorhinolaryngology (45 citations), Pulmonary and Respiratory Medicine (209 citations) and Genetics (60 citations). Li Bian has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Zefei Jiang, Shaohua Zhang, Xiao‐Jing Wang, Gangwen Han, Yongwen He, Christian D. Young, Yi Liu, Bing Liu, Haixu Hu and Shikai Wu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Investigative Dermatology, Annals of Translational Medicine, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.